IPOE looking for a possible retracement in March up to 24.70$ (28%+ Upside) with strong resistance at 21$. IPOE is currently sitting above the 50 day SMA line, with the MACD looking to roll over green, and the RSI is oversold. Price action might be heavily variable due to IPOE & Sofi merging this month, negative sentiment in the SPAC market right now, and the...
CLOV has not received much love these past few weeks after the short report from Hindenburg came out, but I believe that the short report does not hold much substance as well as the fact that CLOV had posted phenomenal earnings. CLOV stock had dropped about 12% after reporting great earnings but weak guidance for 2021. CLOV is also being investigated by the DOJ...
IPOE looking for a possible retracement in March up to 24.70$ (28%+ Upside) with strong resistance at 21$. Price action might be heavily variable due to IPOE & Sofi merging this month, negative sentiment in the SPAC market right now, and the possible ripple effect from Clover Health's SEC investigation. This is not financial advice, I am not advocating the buying...
From 2019 to 2020, $CLOV posted a total revenue growth from $462.3M to $672.9M, net premium revenue growth from $456.9M to $665.7M, decrease in net loss from -$363.7M to -$91.6M, and a decrease in adjusted EBITDA loss from -$175.5M to -$74.4M, among others. $CLOV also saw a 36.3% increase in membership and a 43.2% year-over-year increase in lives under Clover...
$CLOV, the healthcare SPAC $IPOC finally broke its descending channel and is headed towards its first target at 12.50 area. This is Chamath Palihapitiya's controversial SPAC that went down on lawsuit news, but as the dust settles it should ramp up like the other ones he brought to the public market. Not financial advice, DYODD!
After being hit by a short-seller report published by Hindenburg Research on 02/04/2021, we saw $CLOV share price declining steadily up till the current value of $10.98 as of closing price Friday. Clover Health Investments Corp is a company that operates as a Medicare Advantage insurer in the United States by providing preferred provider organization and health...
I think CLOV will begin an uptrend and to make an entry right now could possibly be a very good swing trading opportunity. A lot of interest is drawn to the stock as what I can see right now on different forums and platforms. Imo I don't want to miss this. Let's see how this ages:)!
Currently holding a long position. Support is at $22 and $18. I am expecting a huge rally after SOFI merger date is released. We are still in an uptrend.
$CLOV was consolidating after a retracement down. After consolidation and approaching the edge of a wedge indicating a big movement. They were unexpectedly the target of a short sellers report which caused the movement to continue downward. With a well articulated rebuttal the doc was able to rally and bounce back up. We appear to be at the bottom of a bearish...
Another one of Chamath's SPACs that is trading well below the volume profile POC. POC currently sits around $15.75, current price trading well below it. Great value to enter/add for a swing long.
Based on volume profile, we have a POC around the $14 level, currently trading under. Great value on price for where the majority of the volume sits at. This is also one of Chamath's SPACs, this one has the largest trust fund value. Hopefully Chamath will find a great company to merge with. He's teased Plaid (fintech) before on Twitter. With the right merger, we...
IPOF will receive news from its founder and CEO Chamath Palihapitiya very soon. (Stock price prediction based on chart)
Today I am exclusively looking for SPACs that are as close as possible to $10 (also known as 'NAV') and have quality teams. Not fussy about what stage they're at in the process. $CRHC - Cohn Robbins Holdings Corp * currently searching, not targeting specific industry * solid team: Cohn former director of National Economic Council (NEC) and ex Goldman Sachs...
This is a follow-up post from my previous $SPCE analysis on October 4th titled "$SPCE Love Space Travel, But You May Want To Wait Before Buying". Technical Analysis In my previous post, when $SPCE was priced at $20.77 before the moon towards the October 20th's Highs of $24.36, I talked about how at that point in time, $SPCE had 2 unfilled gaps at $24.02 and...
Technical Analysis Currently, $SPCE is respecting a Symmetrical Triangle chart pattern, where neither the buyers nor the sellers are pushing the price far enough to form a clear trend. As of 4/10/2020, the price closed at $20.77, at the slope of lower highs. Even though I believe that $SPCE has explosive long-term growth potential, assuming that the company is...
News of Blackstone Group L.P. and Fortress Investment Group LLC buying Social Capital Hedosophia Holdings Corp. is fairly bullish and new RSI support has been formed and will provide liftoff from the descending triangle IPOA.U has been living in since creation. There will be a good parabolic movement when we are able to escape. Catalyst: News that the SPAC will...